Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

קרןNational Cancer Institute/NIH
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון28/09/2018
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine
תיאור

This grant solicits applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community.

 

Funding: $300,000 per year

Duration: 3 years 

 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 28.1.18, 29.4.18,28.8.18

Full proposal due date: 28.2.18, 29.5.18, 28.9.18

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 21/11/2017
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive